Paper28073099
Golden root: A wholesome treat of immunity.
Khanna K and 3 others. Biomed Pharmacother, 2017. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. Golden root: A wholesome treat of immunity. Papers, record 28073099. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28073099
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunity | Major topic |
| Plant Extracts | Major topic |
| Rhodiola | Major topic |
| Animals | |
| Humans | |
| Plant Roots | |
| Plants, Medicinal |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42720006 | Mechanistic Investigation of Salidroside Modulates Iron Overload to Mitigate Radiation-Induced Heart Disease. | Cardiovasc Ther | 2026 | https://conductscience.org/library/papers/42720006 | PubMed |
| 40926993 | Chinese herbal medicines: the modifier of hepatocellular carcinoma targeting Wnt/β-catenin signaling pathway. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40926993 | PubMed |
| 40699724 | Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry and Network Pharmacology Reveal the Mechanisms of Rhodiola crenulata in Improving Non-Alcoholic Fatty Liver Disease. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40699724 | PubMed |
| 40102501 | Rhodiola crenulata induces apoptosis in bone metastatic breast cancer cells via activation of caspase-9 and downregulation of MtMP activity. | Sci Rep | 2025 | https://conductscience.org/library/papers/40102501 | PubMed |
| 38396794 | The Role of Rosavin in the Pathophysiology of Bone Metabolism. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38396794 | PubMed |
| 37569669 | Phenolic Compounds of Rhodiola rosea L. as the Potential Alternative Therapy in the Treatment of Chronic Diseases. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37569669 | PubMed |
| 37439434 | Salidroside affects the Th17/Treg cell balance in aplastic anemia via the STAT3/HIF-1α/RORγt pathway. | Redox Rep | 2023 | https://conductscience.org/library/papers/37439434 | PubMed |
| 37370698 | The Potent Anti-Tumor Effects of Rhodiola Drinking Are Associated with the Inhibition of the mTOR Pathway and Modification of Tumor Metabolism in the UPII-Mutant Ha-Ras Model. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37370698 | PubMed |
| 37359549 | The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. | Front Immunol | 2023 | https://conductscience.org/library/papers/37359549 | PubMed |
| 36838523 | Bioactivity Profiles on 15 Different Effect Mechanisms for 15 Golden Root Products via High-Performance Thin-Layer Chromatography, Planar Assays, and High-Resolution Mass Spectrometry. | Molecules | 2023 | https://conductscience.org/library/papers/36838523 | PubMed |
| 35009127 | Optimization of Biomass Accumulation and Production of Phenolic Compounds in Callus Cultures of Rhodiola rosea L. Using Design of Experiments. | Plants (Basel) | 2022 | https://conductscience.org/library/papers/35009127 | PubMed |
| 34988733 | Green synthesis of silver nanoparticles using Rhodiola imbricata and Withania somnifera root extract and their potential catalytic, antioxidant, cytotoxic and growth-promoting activities. | Bioprocess Biosyst Eng | 2022 | https://conductscience.org/library/papers/34988733 | PubMed |
| 32560471 | Protective Evaluation of Compounds Extracted from Root of Rhodiola rosea L. against Methylglyoxal-Induced Toxicity in a Neuronal Cell Line. | Molecules | 2020 | https://conductscience.org/library/papers/32560471 | PubMed |
| 31434310 | Supplementation of Plants with Immunomodulatory Properties during Pregnancy and Lactation-Maternal and Offspring Health Effects. | Nutrients | 2019 | https://conductscience.org/library/papers/31434310 | PubMed |
| 30393593 | Rhodiola rosea L.: an herb with anti-stress, anti-aging, and immunostimulating properties for cancer chemoprevention. | Curr Pharmacol Rep | 2017 | https://conductscience.org/library/papers/30393593 | PubMed |
| 30004426 | Simultaneous Preparation of Salidroside and p-Tyrosol from Rhodiola crenulata by DIAION HP-20 Macroporous Resin Chromatography Combined with Silica Gel Chromatography. | Molecules | 2018 | https://conductscience.org/library/papers/30004426 | PubMed |
| 29987045 | Scleral hypoxia is a target for myopia control. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/29987045 | PubMed |
| 29214185 | Administration of Rhodiola kirilowii Extracts during Mouse Pregnancy and Lactation Stimulates Innate but Not Adaptive Immunity of the Offspring. | J Immunol Res | 2017 | https://conductscience.org/library/papers/29214185 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28073099
GET https://conductscience.org/api/papers/v1/28073099/authors